Literature DB >> 19936883

CSF proteomic analysis in patients with normal pressure hydrocephalus selected for the shunt: CSF biomarkers of response to surgical treatment.

Antonio Scollato1, Alessandro Terreni, Anna Caldini, Benedetta Salvadori, Pasquale Gallina, Simona Francese, Guido Mastrobuoni, Giuseppe Pieraccini, Gloriano Moneti, Luca Bini, Gianni Messeri, Nicola Di Lorenzo.   

Abstract

The aim of our pilot study was to investigate, by a proteomic approach, the expressed differences in cerebrospinal fluid (CSF) protein patterns in order to aid in the diagnosis and treatment of normal pressure hydrocephalus (NPH). Seventeen patients with NPH, selected by Intracranial-Pressure monitoring (ICPmo), underwent implantation of a shunt and after 6 months were clinically re-evaluated. Thirteen patients improved, whereas four did not. During ICPmo CSF was collected and its proteoma was analyzed by 2D gel electrophoresis and mass spectrometry. The over-expression of alpha2HS glycoprotein, alpha1 antichimotrypsin and alpha1beta glycoprotein and the under-expression of glial fibrillary acidic protein, apolipoproteins (AIV, J and E), complement C3c, anti-thrombin, alpha2 antiplasmin and albumin seem to be associated with a positive response to surgery. Most of these proteins have been reported to be altered in Alzheimer disease, supporting the hypothesis of a possible link between these two nosological entities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19936883     DOI: 10.1007/s10072-009-0181-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  49 in total

Review 1.  Ageing choroid plexus-cerebrospinal fluid system.

Authors:  J E Preston
Journal:  Microsc Res Tech       Date:  2001-01-01       Impact factor: 2.769

2.  SYMPTOMATIC OCCULT HYDROCEPHALUS WITH "NORMAL" CEREBROSPINAL-FLUID PRESSURE.A TREATABLE SYNDROME.

Authors:  R D ADAMS; C M FISHER; S HAKIM; R G OJEMANN; W H SWEET
Journal:  N Engl J Med       Date:  1965-07-15       Impact factor: 91.245

3.  Analysis of potential diagnostic biomarkers in cerebrospinal fluid of idiopathic normal pressure hydrocephalus by proteomics.

Authors:  X Li; M Miyajima; R Mineki; H Taka; K Murayama; H Arai
Journal:  Acta Neurochir (Wien)       Date:  2006-06-06       Impact factor: 2.216

4.  Dutch normal-pressure hydrocephalus study: prediction of outcome after shunting by resistance to outflow of cerebrospinal fluid.

Authors:  A J Boon; J T Tans; E J Delwel; S M Egeler-Peerdeman; P W Hanlo; H A Wurzer; C J Avezaat; D A de Jong; R H Gooskens; J Hermans
Journal:  J Neurosurg       Date:  1997-11       Impact factor: 5.115

5.  Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system.

Authors:  Annalisa Castagna; Natascia Campostrini; Alessia Farinazzo; Gianluigi Zanusso; Salvatore Monaco; Pier Giorgio Righetti
Journal:  Electrophoresis       Date:  2002-01       Impact factor: 3.535

6.  The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer's type.

Authors:  G D Silverberg; G Heit; S Huhn; R A Jaffe; S D Chang; H Bronte-Stewart; E Rubenstein; K Possin; T A Saul
Journal:  Neurology       Date:  2001-11-27       Impact factor: 9.910

7.  Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases.

Authors:  J Brettschneider; A Claus; J Kassubek; H Tumani
Journal:  J Neurol       Date:  2005-04-01       Impact factor: 4.849

Review 8.  Clusterin and Alzheimer's disease.

Authors:  Miguel Calero; Agueda Rostagno; Blas Frangione; Jorge Ghiso
Journal:  Subcell Biochem       Date:  2005

9.  Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease.

Authors:  Maja Puchades; Sara Folkesson Hansson; Carol L Nilsson; Niels Andreasen; Kaj Blennow; Pia Davidsson
Journal:  Brain Res Mol Brain Res       Date:  2003-10-21

10.  Hydrocephalus decreases chloride efflux from the choroid plexus epithelium.

Authors:  N W Knuckey; J Preston; D Palm; M H Epstein; C Johanson
Journal:  Brain Res       Date:  1993-08-06       Impact factor: 3.252

View more
  4 in total

1.  Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus.

Authors:  Ville Leinonen; Lata G Menon; Rona S Carroll; Donna Dello Iacono; Jeremy Grevet; Juha E Jääskeläinen; Peter M Black
Journal:  Int J Alzheimers Dis       Date:  2011-06-01

Review 2.  The MiRNA Journey from Theory to Practice as a CNS Biomarker.

Authors:  Nicoleta Stoicea; Amy Du; D Christie Lakis; Courtney Tipton; Carlos E Arias-Morales; Sergio D Bergese
Journal:  Front Genet       Date:  2016-02-09       Impact factor: 4.599

Review 3.  Cerebrospinal fluid and venous biomarkers of shunt-responsive idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis.

Authors:  Santhosh G Thavarajasingam; Mahmoud El-Khatib; Kalyan V Vemulapalli; Hector A Sinzinkayo Iradukunda; Joshua Laleye; Salvatore Russo; Christian Eichhorn; Per K Eide
Journal:  Acta Neurochir (Wien)       Date:  2022-03-01       Impact factor: 2.816

4.  Inference of Diagnostic Markers and Therapeutic Targets From CSF Proteomics for the Treatment of Hydrocephalus.

Authors:  Arie Horowitz; Pascale Saugier-Veber; Vianney Gilard
Journal:  Front Cell Neurosci       Date:  2020-10-21       Impact factor: 5.505

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.